NCT01284959View on ClinicalTrials.gov

Different Safety Profile of Risperidone and Paliperidone Extended-release

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

December 31, 2010

Conditions
Schizophrenia
Interventions
DRUG

risperidone

risperidone 3mg, PO, 3 times

DRUG

paliperidone ER

paliperidone ER 6mg, PO,3 times

DRUG

placebo

lactose PO, 3times

Trial Locations (1)

Unknown

Chonbuk national university hospital, Jeonju

Sponsors
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Janssen Korea, Ltd., Korea

INDUSTRY

collaborator

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

collaborator

Sanofi-Synthelabo

INDUSTRY

lead

Chonbuk National University Hospital

OTHER